Trials / Terminated
TerminatedNCT02702713
Pivotal Assessment of the Effects of Bioactive on Health and Wellbeing. From Human Genome to Food Industry
Investigation of the Effect of Daily Consumption of Bioactive Enriched Foods (BEF) on Biochemical and Anthropometric Markers of Metabolic Syndrome (MS)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 325 (actual)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This is a multi-centre, randomised, double-blind, placebo-controlled, parallel-arm dietary intervention study. In total, 800 men and women at risk for Metabolic Syndrome (MS) will be recruited. Subjects will be eligible to the study if they present with two to four of the MS diagnostic criteria, at least one of them being: * fasting triglycerides ≥150 mg/dL but ≤400 mg/dL OR * HDL-cholesterol ≤50 mg/mL in women, ≤ 40mg/mL in men (with fasting triglycerides ≥110 mg/dL). Each of the four recruiting centres will recruit 200 volunteers. Participants will be randomly assigned to one of four groups to receive either: * Dairy BEF + egg placebo + bakery placebo * Egg BEF + dairy placebo + bakery placebo * Bakery BEF + dairy placebo + egg placebo * Dairy, egg and bakery placebo Participants will be required to consume all three of the allocated products each day for 12 weeks. Eligible volunteers will be included and randomly allocated to one of the four groups. At baseline, 6 weeks and 12 weeks after inclusion, each participant will visit the recruiting centre for clinical and biochemical investigations. At 3 weeks and 9 weeks participants will complete questionnaires relating to their satisfaction with the food products, compliance to consumption of the study food products, and any gastrointestinal side effects or health-related adverse events that have occurred in the previous 3 weeks. At each recruiting centre 40 participants will be required to take part in additional activities, these are: stool sample collection, adipose tissue aspiration, body composition analysis by dual energy x-ray absorptiometry (DEXA) and assessment of physical activity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Dairy BEF | Dairy BEF: Milkshake powder enriched with 250 mg of DHA and 3g beta-glucans |
| DIETARY_SUPPLEMENT | Egg BEF | Egg BEF: Frozen pancakes enriched with 250 mg of DHA and 320 mg of anthocyanins |
| DIETARY_SUPPLEMENT | Bakery BEF | Bakery BEF: Biscuits enriched with 250 mg of DHA and 320 mg of anthocyanins |
| DIETARY_SUPPLEMENT | Bakery placebo | Bakery placebo: Biscuits without enrichment |
| DIETARY_SUPPLEMENT | Dairy placebo | Dairy placebo: Milkshake powder without enrichment |
| DIETARY_SUPPLEMENT | Egg placebo | Egg placebo: Frozen pancakes without enrichment |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2017-10-20
- Completion
- 2017-10-20
- First posted
- 2016-03-09
- Last updated
- 2017-12-02
Locations
4 sites across 4 countries: France, Germany, Italy, United Kingdom
Source: ClinicalTrials.gov record NCT02702713. Inclusion in this directory is not an endorsement.